Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 28 April 2016

Bagsværd, Denmark, 28 April 2016 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.

Further information

Media:   
Anne Margrethe Hauge+45 3079 3450 amhg@novonordisk.com
 

Investors:
  
Peter Hugreffe Ankersen+45 3075 9085 phak@novonordisk.com
Daniel Bohsen+45 3079 6376 dabo@novonordisk.com
Melanie Raouzeos+45 3075 3479 mrz@novonordisk.com
Kasper Veje+45 3079 8519 kpvj@novonordisk.com

Company announcement No 33 / 2016

Company announcement No 33 / 2016



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via GlobeNewswire

HUG#2007914